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Cationic amino acid transporter mRNA expression in kidney and
liver. Expression of rat cationic amino acid transporter 2 (r-
CAT-2) mRNA was studied in kidney and liver using Northern
blot analysis and nonradioactive in situ hybridization with a probe
identifying both the r-CAT-2a and -2b splice variants. Expression
of r-CAT-2 mRNA was higher in the liver than in the kidney.
Within the kidney, r-CAT-2 mRNA was more abundant in the
outer and inner medulla than in the cortex. In the liver lobule, the
intensity of the hybridization signal in hepatocytes decreased
between the portal area and the central vein. In the kidney,
hybridization signals were detected in parietal cells of Bowman‘s
capsule, various tubule cells of outer and inner medulla, in
endothelial and interstitial cells of inner medulla, and in papillary
epithelial cells.
The key role of cationic amino acids (CAs) in protein
synthesis as sources of metabolic energy and as precursors
of biologically important molecules, including polyamines,
carnitine, phosphocreatine, and NO, is well established. CA
turnover in liver and other tissues is determined, in part, by
the activity of specific carriers that recognize CAs with high
affinity, that are Na1 independent, and that are activated
by the substrate on the opposite site of the membrane.
Recently, the genes encoding proteins responsible for this
type of transport have been cloned and designated as
CA-transporter (CAT)-1, CAT-2a, and CAT-2b [1]. Both
CAT-1 and CAT-2b are low-capacity, high-affinity (km '
100 mM) CATs. CAT-2a, in contrast, is a low-affinity (km 2
to 5 mM), high-capacity alternate splice variant of CAT-2b
cloned from murine liver [2]. Interest in CATs was stimu-
lated by the discovery that the CA arginine is the exclusive
precursor of nitric oxide (NO), and cellular uptake of
arginine is required for NO production in many cells. We
thus investigated the expression of the rat CAT-2 (r-
CAT-2) in kidney and liver using nonradioactive in situ
hybridization and Northern blot analyses. METHODS
Total RNA from inner medulla, outer medulla, cortex,
and liver of 5- to 7-week-old female Wistar rats (Charles
River, Sulzfeld, Germany) was isolated using Tri Reagent
(Biozol, Eching, Germany). RNA yield and purity were
estimated spectrophotometrically by absorbance at 260 and
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Fig. 1. Reverse transcription polymerase chain reaction for the rat
cationic amino acid transporter-2 (r-CAT-2) digoxigenin-probe of RNA
from liver. A molecular size marker is shown on the left.
Fig. 2. Northern blot analyses of rat cationic amino acid transporter-2
(r-CAT-2). (A) mRNA levels in kidney [inner medulla (IN), outer medulla
(OM), cortex (c)] and liver. Total RNA (20 mg) was size separated on a
1.0% formaldehyde-agarose gel and transferred to a nylon membrane and
hybridized with a digoxigenin-labeled r-CAT-2 cDNA probe. (B) Relative
abundancy of r-CAT-2 mRNA in liver and kidney.
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280 nm. The integrity of the RNA was checked on a
nondenaturing agarose gel. Total RNA (3 mg) from the
liver was reverse transcribed with the “Ready To Go
T-Primed First-Strand” Kit (Pharmacia, Freiburg, Germa-
ny). A 2-ml aliquot of the reverse transcriptase-polymerase
chain reaction (RT-PCR) reaction from liver RNA was
used to obtain the CAT-2 probe, which identifies both
splice variants. To obtain highly specific, single-stranded
probes, a nucleotide solution with 0.35 mM digoxigenin-
dUTP (Boehringer Mannheim, Mannheim, Germany) was
used for polymerase chain reaction (PCR) (94°C denatur-
ation, 58°C annealing, 72°C extension, 35 cycles), using
specific forward (59-CCC GAG TAT CGT GGT GTC
TT-39) and reverse (59-CAA CGT CCC TGT AAA GCC
AT-39) primers yielding a 580-bp product (Fig. 1). A
glyceraldehyde-3-phosphate dehydrogenase probe was am-
plified by PCR (94°C denaturation, 63°C annealing, 72°C
extension, 35 cycles) with specific primers (sense: 59-CCA
GTG AGC TTC CCG TTC AGC-39, antisense: 59-CCC
ATC ACC ATC TTC CAG GAG C-39, product length 471
bp). Digoxigenin-labeled probes were purified with QIA-
quick Spin Columns (QIAquick PCR Purification Kit;
Qiagen, Hilden, Germany).
Northern blot analysis was performed by standard meth-
ods. The hybridization with nonradioactive probes and
their detection was performed as described elsewhere [3].
Fig. 3. Light micrographs showing pattern of nonradioactive in situ hybridization of the digoxygenin-labeled rat cationic amino acid transporter-2
(r-CAT-2) probe in paraffin-embedded sections of rat liver (A) and kidney (B). Abbreviations for liver are: central vein (CV), portal canal (PC). The
section passes through some of the sinusoids (S) as they open into the central vein. Abbreviations for the kidney are: inner medulla (IM), outer medulla
(OM), and cortex (c).
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For in situ hybridization, the digoxigenin-labeled probe
was cut with restriction enzymes into a probe cocktail of
varying lengths (ApaI, AluI). Kidneys and livers were fixed
routinely in formalin and embedded in paraffin. Paraffin
sections (5 mm) were mounted on siliconized slides, hy-
drated in decreasing ethanol concentrations, and pre-
treated with 1 M sodium thiocyanate at 80°C and 0.01%
proteinase K in tris(hydroxymethyl)aminomethane HCl
(Tris-HCl), pH 7.5 at 37°C. The sections were postfixed (10
min) in 4% paraformaldehyde in 0.1 M phosphate buffer at
4°C, washed in Tris-HCl, and dehydrated in increasing
ethanol concentrations. Tissue sections and the probe were
denatured at 80°C and hybridized for 24 hours at 37°C in
buffer [53% deionized formamide, 10% dextran sulphate,
10% Denhardt’s solution and 2 3 standard saline citrate
(SSC), pH 7.0] containing the digoxigenin-labeled probe
(final concentration 1 ng/ml). Following hybridization, sec-
tions were immersed in 2 3 SSC at 65°C and 0.1 3 SSC at
45°C for five minutes each. After washing in Tris-HCl-
buffer, the sections were incubated in blocking buffer
(Boehringer) and then with an antidigoxygenin antibody-
alkaline phosphatase conjugate (dilution 1:500 in Tris-HCl-
buffer; Boehringer) for 30 minutes at room temperature.
The color substrate for the alkaline phosphatase was
4-nitroblue tetrazolium chloride plus 5-bromo-4-chloro-3-
indolyl-phosphate.
RESULTS AND DISCUSSION
Expression of r-CAT-2 mRNA was higher in liver than in
the kidney (Fig. 2). Within the kidney, r-CAT-2 mRNA is
more abundant in outer than in inner medulla. Expression
of the CAT mRNA in the renal cortex was low (Fig. 2). In
the portal area of the liver lobule, vessel cells and the bile
duct stained intensely. In this area, the hepatic cells also
show high r-CAT-2 mRNA expression. The signal intensity
in hepatic cells decreases towards the central vein (Fig.
3A). In the hepatic lobule, mRNA coding for the a isoform
and b isoform of CAT-2 is thus expressed heterogenously.
The decrease in staining intensity of hepatocytes between
the portal area and the central vein may be explained by
declining concentrations of CAs as blood flows toward the
central vein.
In the renal cortex, low staining intensity was found in
single collecting duct cells and in parietal cells of Bowman’s
capsule. In the medulla, r-CAT-2 mRNA signals were
detected in proximal straight tubule cells, collecting duct,
and the thick ascending limb of Henle’s loop. In inner
medulla, staining was found in collecting duct cells, thin
limbs of Henle’s loop, capillary endothelium, the epithe-
lium lining the papillary tip, and interstitial cells (Fig. 3B).
Because CAT mediates the uptake of the NO precursor
arginine and because most of this transporter may play a
role in the regulation of NO production in kidney cells, it is
conceivable that the cells exhibiting CAT-2 mRNA staining
also express NO synthase [4].
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